28th Regular Meeting of the CCM/E Oversight Committee February 17th 2026
The Country Coordinating Mechanism (CCM/E) Oversight Committee (OC) held its 28th regular meeting for a full day on Tuesday, February 17th, 2026, in Addis Ababa, Ethiopia. The session was chaired by Dr. Neghist Tesfaye Chairperson and Mrs. Robin Gorna vice chairperson of the OC.
The primary focus of the meeting was to thoroughly review the progress and performance of the Global Fund grants, including activities related to HIV, Tuberculosis (TB), Malaria, Resilience and Sustainable Systems for Health (RSSH), and the COVID-19 Response Mechanism (C-19RM), specifically covering Grant Period 6 (October – December 2025) based on Principal Recipient (PR) dashboards.
Key objectives included discussing the performance of the Global Fund GC7 Grant, assessing the status of agreed action items, and identifying new bottlenecks and challenges affecting grant implementation and performance, ultimately aiming to suggest essential solutions and recommendations for CCM/E decisions. Participants included OC members, PRs’ Program, M&E, PSM, and Finance Focal points, and representatives from Federal Level Implementing Entities such as EPSS, EFDA, EPHI, NEP+, CCRDA, OSSHD, ISHDO, Love in Action Ethiopia, and CHAI. The meeting included detailed presentations: Mr. Abayneh Admas, interim Executive secretary, Oversight and Compliance Officer, presented the summary of all grant performances for Period 6, detailing programmatic indicators, cumulative disbursement, allocated GC7 budget, absorption rates, and identified gaps. Following this, Mr. Fekede Shiferaw, Senior Supply Chain Manager at Ethiopian Pharmaceuticals and Supply service (EPSS), provided an update on commodity procurement status and current stock levels for each grant. A detailed analytical review and structured discussion followed the presentations, with members and participants thoroughly reviewing the programmatic performance, examining the performance variances among Sub-Recipients (SRs) and Sub-Sub-Recipients (SSRs), and critically assessing the impact of delays on essential commodity stock status. The Oversight Committee drafted focused action points for the PR grant focal point, and these will be shared with the CCM/E on the next regular meeting for approval.
